Valeant (VRX) August weekly volatility elevated as shares up in premarket on Q2 and outlook

Valeant Pharma (NYSE: VRX) is recently up $1.55 to $24 in the premarket on backs FY16 revenue guidance of $9.9B-$10.1B, compared to consensus $10.01B. August weekly call option implied volatility is at 147, August is at 109, September is at 84; compared to its 52-week range of 34 to 175.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Meta Platforms (META) call put ratio 1.7 calls to 1 put
• Alphabet (GOOGL) 12K contracts of July 420 calls trade